These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 340947)

  • 1. Predicting treatment costs and life expectancy for end-stage renal disease.
    Stange PV; Sumner AT
    N Engl J Med; 1978 Feb; 298(7):372-8. PubMed ID: 340947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic realities in uremia therapy.
    Friedman EA; Delano BG; Butt KM
    N Engl J Med; 1978 Feb; 298(7):368-71. PubMed ID: 340946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of hemodialysis versus cadaveric transplantation.
    Kreis H
    Kidney Int Suppl; 1978 Jun; (8):S91-4. PubMed ID: 357819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are home hemodialysis aides cost-effective? Cost of home hemodialysis aides.
    Roberts SD; Maxwell DR; Gross TL
    Arch Intern Med; 1981 Jun; 141(7):855-8. PubMed ID: 6786234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost comparison of in-center dialysis, home dialysis, and transplantation in the Nashville area.
    Thompson K
    Nephrol Nurse; 1980; 2(6):23-4. PubMed ID: 7003421
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of kidney transplantation and hemodialysis.
    Douglas RA
    Transplant Proc; 1973 Jun; 5(2):1043-6. PubMed ID: 4579036
    [No Abstract]   [Full Text] [Related]  

  • 11. The costs of domiciliary maintenance haemodialysis. A comparison with alternative renal replacement regimens.
    Stewart JH; Topp ND; Martin S; Schawrowas E; Flaus Y; Sheil AG; Mahony JF
    Med J Aust; 1973 Jan; 1(4):156-9. PubMed ID: 4571627
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effective care of end-stage renal disease: a billion dollar question.
    Roberts SD; Maxwell DR; Gross TL
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):243-8. PubMed ID: 6766290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The politics of health cost containment: end-stage renal disease.
    Rettig RA
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract]   [Full Text] [Related]  

  • 14. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M; Rottembourg J
    Ann Med Interne (Paris); 1982; 133(8):611-24. PubMed ID: 6763488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost-effectiveness of increasing kidney transplantation and home-based dialysis.
    Howard K; Salkeld G; White S; McDonald S; Chadban S; Craig JC; Cass A
    Nephrology (Carlton); 2009 Feb; 14(1):123-32. PubMed ID: 19207859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and program costs associated with chronic hemodialysis care.
    Pearson DA; Stranova TJ; Thompson JD
    Inquiry; 1976 Mar; 13(1):23-8. PubMed ID: 130346
    [No Abstract]   [Full Text] [Related]  

  • 19. An interview with Rep. Charles A. Vanik (D-OH).
    Lesparre M; Vanik A
    Hospitals; 1976 Jul; 50(14):45-6, 49-50. PubMed ID: 780255
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.